ES2421932T3 - Formulaciones de espuma para el tratamiento de enfermedades cutáneas en los animales - Google Patents

Formulaciones de espuma para el tratamiento de enfermedades cutáneas en los animales

Info

Publication number
ES2421932T3
ES2421932T3 ES10155548T ES10155548T ES2421932T3 ES 2421932 T3 ES2421932 T3 ES 2421932T3 ES 10155548 T ES10155548 T ES 10155548T ES 10155548 T ES10155548 T ES 10155548T ES 2421932 T3 ES2421932 T3 ES 2421932T3
Authority
ES
Spain
Prior art keywords
treatment
skin diseases
animals
foam formulations
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10155548T
Other languages
English (en)
Inventor
Thomas Neubourg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neubourg Skin Care GmbH and Co KG
Original Assignee
Neubourg Skin Care GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neubourg Skin Care GmbH and Co KG filed Critical Neubourg Skin Care GmbH and Co KG
Application granted granted Critical
Publication of ES2421932T3 publication Critical patent/ES2421932T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Una formulación de espuma que comprende una emulsión, que comprende una fase oleosa y una fase acuosa,comprendiendo la emulsión microplata y/o urea, destinada a la utilización en la prevención y/o el tratamiento de unaenfermedad cutánea en el caso de mamíferos no humanos, escogiéndose la enfermedad cutánea entre el conjuntoformado por la dermatitis erastines, la dermatitis seborreica o unas enfermedades cutáneas similares.
ES10155548T 2010-03-04 2010-03-04 Formulaciones de espuma para el tratamiento de enfermedades cutáneas en los animales Active ES2421932T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10155548.0A EP2371350B1 (de) 2010-03-04 2010-03-04 Schaumformulierungen zur Behandlung von Hauterkrankungen beim Tier

Publications (1)

Publication Number Publication Date
ES2421932T3 true ES2421932T3 (es) 2013-09-06

Family

ID=43432228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10155548T Active ES2421932T3 (es) 2010-03-04 2010-03-04 Formulaciones de espuma para el tratamiento de enfermedades cutáneas en los animales

Country Status (3)

Country Link
EP (1) EP2371350B1 (es)
ES (1) ES2421932T3 (es)
PL (1) PL2371350T3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2978664B1 (fr) * 2011-08-04 2014-01-10 Petcare Innovation Composition antiseptique

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1014916E (pt) 1997-08-18 2002-06-28 Neubourg Stephanie Espuma creme de proteccao dermatologica
EP1287814A1 (de) 2001-09-04 2003-03-05 Kramer, Axel, Prof.Dr.med.habil. Wirkstoffkombination mit Rhodanid (Thiocyanat) als Hauptwirkstoff
US20040156874A1 (en) 2003-02-11 2004-08-12 Bradley Pharmaceuticals, Inc. Urea- a topical anti-inflammatory
IL162606A (en) 2003-08-13 2011-03-31 Perrigo Israel Pharmaceuticals Ltd Topical compositions of urea and ammonium lactate
DE202006004676U1 (de) 2005-09-28 2007-02-08 Neubourg Skin Care Gmbh & Co. Kg Hautpflegeprodukte
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
EP2020221B1 (de) 2007-06-19 2012-02-29 Neubourg Skin Care GmbH & Co. KG DMS (Derma Membrane Structure) in Schaum-Cremes
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
DE102007044582A1 (de) 2007-09-19 2009-04-09 Deckner, Peter G., Dr. med. Zusammensetzung für Wundbehandlungen im Humanbereich
EP2095807A1 (de) * 2008-02-28 2009-09-02 Chanh-Dinh Nguyen-Petersen Creme gegen Cellulite und Sommersprossen
DE102008031023A1 (de) 2008-06-30 2009-12-31 Neubourg Skin Care Gmbh & Co. Kg Schaumhautpflegecreme

Also Published As

Publication number Publication date
EP2371350B1 (de) 2013-04-24
HK1162309A1 (en) 2012-08-31
EP2371350A1 (de) 2011-10-05
PL2371350T3 (pl) 2013-09-30

Similar Documents

Publication Publication Date Title
NI201400842A (es) Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas.
BR112014025711A2 (pt) composto, medicamento, e, uso de um composto
UY34997A (es) Agente de control de endoparásitos y método para usarlo
PE20150200A1 (es) Formulacion de anticuerpos
CL2014000601A1 (es) Composición tópica veterinaria que comprende al menos un agente activo derivado de isoxazolina; y uso de la composición para el tratamiento o prevención de una infestación o infección por parásitos en un animal.
CL2014002250A1 (es) Combinacion que comprende tiazolilisoxazolina y al menos un compuesto activo adicional; procedimiento para controlar hongos fitopatogenos y sus usos.
CL2015003690A1 (es) Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington.
CL2014000995A1 (es) Composicion de prodroga que comprende un conjugado de hidromorfona y un acido arilcarboxilico; un método para tratar un paciente que comprende la administracion de la composicion.
CL2015000408A1 (es) Compuestos derivados de pirazolo[4,3-d]pirimidina y sus sales; composicion farmaceutica que los comprende, util para el tratamiento de enfermedades alergicas, inflamatorias, infecciosas o cancer.
UY32554A (es) Compuestos peptidomiméticos de sulfonamida y usos antivirales de los mismos
BR112015014885A2 (pt) combinação de agentes ativos, composição cosmética e/ou dermatológica e processo para a preparação de uma composição de agentes ativos.
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CL2015000434A1 (es) Metodo para el tratamiento, prevencion o disminucion de la severidad de una condicion o trastorno no neoplasico de la piel que comprende administrar un compuesto derivado de retinoides; composicion dermica que comprende los derivados de retinoide.
PT3016666T (pt) Formulação de óleo marinho que compreende resveratrol ou derivados do mesmo para utilizar no tratamento, retardamento e/ou prevenção de doença de alzheimer
PY1361141A (es) Composiciones acuosas de cloquintocetmexilo de temperatura estable
MX2015011775A (es) Uso de levocetirizina y montelukast en el tratamiento de anafilaxis.
MX2015011497A (es) Gel de acido salicilico.
CR20140521A (es) Formulación insecticida de agua en aceite (ag/ac)
ES2722926T3 (es) Combinación de levocabastina y furoato de fluticasona para el tratamiento de condiciones inflamatorias y/o alérgicas
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
CO6450623A2 (es) Parasiticidas sanguineos
MX2017007856A (es) Composicion para el cuidado bucal.
ES2421932T3 (es) Formulaciones de espuma para el tratamiento de enfermedades cutáneas en los animales
CL2013003808A1 (es) Formulacion veterinaria que comprende un extracto etanolico de s. adenotrichius dc donde el extracto etanolico comprende un compuesto sesquiterpeno eremofilano de formula i; uso para prevenir, controlar o eliminar garrapatas o sus larvas en un animal o humano, y en el entorno de los mismos.
BR112016016674A2 (pt) Agente terapêutico ou profilático para uso no tratamento de esclerose múltipla